High-dose melphalan and autologous bone marrow transplantation as consolidation in previously untreated myeloma.

David Cunningham, Luis Paz‐Ares, S Milan, +7

Journal of Clinical Oncology

Tumour necrosis factor in man: Clinical and biological observations

Peter J. Selby, Stuart Hobbs, C. Viner, +7

British Journal of Cancer

InflammationImmunologyHistopathologyPathologyCell Death +8

INTENSIVE TREATMENT OF MULTIPLE MYELOMA AND CRITERIA FOR COMPLETE REMISSION

Martin Gore, C. Viner, M Meldrum, +12

The Lancet

Hematological MalignancyOncologyHematologyMyeloid NeoplasiaMedicine +2

A randomized trial of maintenance interferon following high‐dose chemotherapy in multiple myeloma: long‐term follow‐up results

David Cunningham, R Powles, J. S. Malpas, +10

British Journal of Haematology

High-dose melphalan for multiple myeloma: long-term follow-up data.

David Cunningham, Luis Paz‐Ares, Martin Gore, +7

Journal of Clinical Oncology

Perspectives on fertility preservation and parenthood among transgender youth and their parents

Lyne Chiniara, C. Viner, Mark R. Palmert, +1

Archives of Disease in Childhood

Tumour necrosis factor, cholestatic jaundice, and chronic liver disease.

Alison Jones, Peter J. Selby, C. Viner, +3

Gut

Hepatic DisordersHepatologyBiliary CancerLiver PhysiologyImmunology +8

Outcome assessment of a population-based group of 195 unselected myeloma patients under 70 years of age offered intensive treatment

R Powles, Noopur Raje, S Milan, +8

Bone Marrow Transplantation

Unselected Myeloma PatientsPrognostic EvaluationHematological MalignancyOncologyHematology +4

A comparison of vincristine and doxorubicin infusional chemotherapy with methylprednisolone (VAMP) with the addition of weekly cyclophosphamide (C‐VAMP) as induction treatment followed by autografting in previously untreated myeloma

Noopur Raje, R Powles, Samar Kulkarni, +10

British Journal of Haematology

Infused vincristine and adriamycin with high dose methylprednisolone (VAMP) in advanced previously treated multiple myeloma patients

Peter J. Selby, Sunil R. Lakhani, G. Zulian, +3

British Journal of Cancer

Hematological MalignancyOncologyHematologyPharmacologyHigh Dose Methylprednisolone +4